EMBC NASDAQ
Parsippany, NJ 07054
US
Embecta Corp. is a medical technology enterprise devoted to enhancing the quality of life and health outcomes for individuals living with diabetes. Its comprehensive product portfolio includes essential tools such as pen needles, syringes, and advanced safety devices. Additionally, the company provides innovative digital applications designed to support patients in effectively managing their condition. Embecta distributes its offerings primarily through a network of wholesalers and distributors, reaching markets both domestically within the United States and across the globe. Established in 1924, Embecta's headquarters are located in Parsippany, New Jersey. The company transitioned to an independent entity from Becton, Dickinson and Company on April 1, 2022.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Morris Milton Mayo | S-Sale | 6,293 | $5.88 | 2026-09-04 |
| Kurdikar Devdatt | P-Purchase | 30,000 | $4.70 | 2026-08-12 |
| Elguicze Jacob | P-Purchase | 20,000 | $4.67 | 2026-08-12 |
| Mann Jeffrey Z | P-Purchase | 20,000 | $4.99 | 2026-08-12 |
| HOMBACH ROBERT J. | P-Purchase | 45,000 | $4.97 | 2026-08-12 |